Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Supplement regulation stories

Sep 16, 2026

CDC investigates glutathione injection outbreak that sickened dozens across four states

More than 25 people across four states became ill after receiving glutathione injections, with at least three hospitalized. The CDC is investigating the outbreak linked to dietary supplement-grade glutathione products, and three Texas compounding pharmacies have issued recalls.

Sep 16, 2026·3 sources
00
Sep 9, 2026

New research highlights benefits and risks of hormone therapy for menopause symptoms

Multiple studies released this week show hormone therapy during menopause may reduce heart disease risk and improve mood symptoms, while supplements marketed for menopause lack evidence and contain inconsistent doses. The research comes amid growing attention to the economic costs of menopause symptoms for women.

Sep 9, 2026·5 sources
00
Jul 27, 2026

UCT Clinicians Warn of Health Dangers from Pre-Workout Supplements After Emergency Case

Researchers at the University of Cape Town have issued a warning about potential health risks associated with pre-workout supplements following a case where an adult patient presented to the emergency unit with chest pain.

Jul 27, 2026·1 source
00
Jul 25, 2026

Analysis finds prebiotic sodas may contain less fiber and more sugar than advertised

A new analysis reveals that many prebiotic sodas, which have surged in popularity with promises of gut health benefits and low-calorie content, may actually contain lower fiber levels and higher sugar content than consumers expect.

Jul 25, 2026·1 source
00
Jul 24, 2026

FDA Advisory Panel Recommends Easing Restrictions on Unapproved Peptides Despite Agency Scientists' Concerns

Outside advisers to the U.S. Food and Drug Administration narrowly voted to recommend broader access to several unapproved peptides popular in wellness circles, backing a push by HHS Secretary Robert F. Kennedy Jr. despite objections from FDA career scientists about limited safety data and potential conflicts of interest among panelists.

Jul 24, 2026·8 sources
00
Jul 22, 2026

FDA panel votes to allow compounding of peptide BPC-157

FDA advisory panel voted to place peptide BPC-157 on a list allowing broader pharmacy compounding, the first of seven peptides under review. The decision supports HHS Secretary RFK Jr.'s push to expand access to these compounds.

Jul 22, 2026·6 sources
00
Apr 16, 2026

FDA Requests Additional Liver Injury Data on Eli Lilly Obesity Pill Foundayo

The FDA has asked Eli Lilly for more data on liver injury linked to its newly approved obesity pill Foundayo.

Apr 16, 2026·1 source
00
Apr 14, 2026

FDA Pushes Drugmakers to Report Missing Clinical Trial Results

FDA officials revealed that nearly 30% of clinical trial studies highly likely to fall under mandatory reporting requirements failed to submit results, prompting new enforcement efforts to improve transparency.

Apr 14, 2026·1 source
00
Apr 11, 2026

Estrogen Patch Shortages Reported Due to Surging Demand for Menopause Treatment

Growing demand for estrogen patches to relieve menopause symptoms has led to widespread shortages across pharmacies, forcing women to search multiple locations or switch medications.

Apr 11, 2026·1 source
00
Apr 7, 2026

Novo Nordisk Launches High-Dose Wegovy for Weight Loss

Novo Nordisk has launched a higher-dose version of its obesity medication Wegovy, intensifying competition in the rapidly growing weight loss drug market.

Apr 7, 2026·1 source
00
Apr 3, 2026

Kratom Poisonings Surge 1,200% Over Past Decade as Regulators Struggle with Safety Concerns

Kratom-related poisonings have increased by 1,200% over the past decade, with proposals to ban or regulate the plant-based substance making headlines across the United States as lawmakers and regulators grapple with safety concerns.

Apr 3, 2026·1 source
00

Poison Centers Report 383% Increase in Kava-Related Calls Between 2011-2025

A new University of Virginia Health study found calls to poison centers about kava, a drug found in drinks marketed as healthy alcohol alternatives, rose 383% over a 14-year period.

Apr 3, 2026·1 source
00

USDA Issues Warning Over Lead-Contaminated Frozen Chicken Nuggets

Food safety officials are warning consumers not to eat certain frozen chicken nuggets after tests found dangerous levels of lead contamination.

Apr 3, 2026·1 source
00
Apr 2, 2026

FDA Approves Eli Lilly's Obesity Pill, Setting Up Competition with Novo Nordisk

The FDA has approved Eli Lilly's oral obesity medication, marking a significant development in the weight-loss drug market and positioning it for direct competition against Novo Nordisk's Wegovy pill.

Apr 2, 2026·1 source
00

Top claims

  • ▪There are currently no Food and Drug Administration-approved glutathione products on the market.
  • ▪All of the compounding pharmacies involved in the recalls obtained their dietary supplement-grade glutathione from Medisca, which is headquartered in Plattsburgh, New York.
  • ▪The Centers for Disease Control and Prevention is investigating an outbreak of more than 25 illnesses across four states linked to glutathione injections.

People involved

Robert F. Kennedy Jr.Donald Trump

Subtopics

Drug Approval and Clinical Trials5Lifestyle, Wellness and Nutrition5Pharma4Supplement safety4Weight management3Addiction & recovery2Bioethicists of life extension2Biohacking & optimization2Cardiovascular health.2Evidence based supplementation2GLP-1 medications2Gut health & microbiome2Hormone optimization2Peptide therapy2Reproductive Health2Addiction and Harm Reduction1Age related cognitive decline1AI policy1AI regulation & lawsuits1Alcohol & sleep1BPC-1571Cardiovascular training1Consumer protection1Eli Lilly1

Related timelines

AI Data Center Gold Rush

101 stories

Congress

108 stories

Crypto hacks

100 stories

Ebola outbreak

58 stories

Iran War

209 stories